According to the Zhitong Finance App, Zhaoyan New Pharmaceutical (06127.HK) announced that from April 20, 2026 to September 23, 2026, the Group's subsidiaries subscribed to these CITIC Securities financial products through CITIC Securities and its subsidiaries (including the first CITIC Securities financial product to the seventh CITIC Securities financial product), and the total investment amount of these CITIC Securities financial products that have not expired on the date of this announcement was RMB 540 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.